Evidence map›Paper›PMID 35091583›Full record

ArticleScientific reports2022

Radiation dose enhancement using gold nanoparticles with a diamond linear accelerator target: a multiple cell type analysis.

Olivia Piccolo, John D Lincoln, Nicole Melong, Benno C Orr, Nicholas R Fernandez, Jennifer Borsavage, Jason N Berman, James Robar, Michael N Ha

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
4.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Microdosimetric Simulation of Gold-Nanoparticle-Enhanced Radiotherapy.International journal of molecular sciences · 2024
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Olivia PiccoloDepartment of Biology, Dalhousie University, Halifax, NS, Canada.
John D LincolnDepartment of Physics and Atmospheric Science, Dalhousie University, Halifax, NS, Canada.
Nicole MelongChildren's Hospital of Eastern Ontario Research Institute/Department of Pediatrics, University of Ottawa, Ottawa, ON, Canada.
Benno C OrrDepartment of Pediatrics, IWK Health Centre/Dalhousie University, Halifax, NS, Canada.
Nicholas R FernandezDepartment of Pediatrics, IWK Health Centre/Dalhousie University, Halifax, NS, Canada.
Jennifer BorsavageDepartment of Physics and Atmospheric Science, Dalhousie University, Halifax, NS, Canada.
Jason N BermanDepartment of Pediatrics, IWK Health Centre/Dalhousie University, Halifax, NS, Canada.
James RobarDepartment of Physics and Atmospheric Science, Dalhousie University, Halifax, NS, Canada.
Michael N HaDepartment of Radiation Oncology, Dalhousie University, Halifax, NS, Canada. Michael.Ha@Dal.Ca.
Dalhousie University · CAIzaak Walton Killam Health Centre · CAUniversity of Ottawa · CA

Funding

Canadian Cancer Society Innovation grant (#705971)
6 · The paper itself

Abstract

Radiotherapy (RT) is an effective cancer treatment modality, but standard RT often causes collateral damage to nearby healthy tissues. To increase therapeutic ratio, radiosensitization via gold nanoparticles (GNPs) has been shown to be effective. One challenge is that megavoltage beams generated by clinical linear accelerators are poor initiators of the photoelectric effect. Previous computer models predicted that a diamond target beam (DTB) will yield 400% more low-energy photons, increasing the probability of interacting with GNPs to enhance the radiation dose by 7.7-fold in the GNP vicinity. After testing DTB radiation coupled with GNPs in multiple cell types, we demonstrate decreased head-and-neck cancer (HNC) cell viability in vitro and enhanced cell-killing in zebrafish xenografts compared to standard RT. HNC cell lines also displayed increased double-stranded DNA breaks with DTB irradiation in the presence of GNPs. This study presents preclinical responses to GNP-enhanced radiotherapy with the novel DTB, providing the first functional data to support the theoretical evidence for radiosensitization via GNPs in this context, and highlighting the potential of this approach to optimize the efficacy of RT in anatomically difficult-to-treat tumors.

Indexed as

DiamondGoldMetal NanoparticlesParticle AcceleratorsZebrafishAnimalsCell Line, TumorCell SurvivalDNA Breaks, Double-StrandedHead and Neck NeoplasmsHumansRadiation DosageRadiation-Sensitizing AgentsXenograft Model Antitumor AssaysDiamondGoldRadiation-Sensitizing Agents

Identifiers

PMID35091583
PMCPMC8799734
OpenAlexW4210781932

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.